Dual Blockade of the Renin-Angiotensin-Aldosterone System: Beyond the ACE Inhibitor and Angiotensin-II Receptor Blocker Combination
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual Blockade of the Renin-Angiotensin-Aldosterone System: Beyond the ACE Inhibitor and Angiotensin-II Receptor Blocker Combination
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HYPERTENSION
Volume 22, Issue 10, Pages 1032-1040
Publisher
Oxford University Press (OUP)
Online
2009-08-06
DOI
10.1038/ajh.2009.138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma Renin Test-Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial
- (2009) B. M. Egan et al. AMERICAN JOURNAL OF HYPERTENSION
- Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
- (2009) Scott D. Solomon et al. CIRCULATION
- Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
- (2009) L. F. Fried et al. Clinical Journal of the American Society of Nephrology
- Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial
- (2009) Karl Andersen et al. JOURNAL OF HYPERTENSION
- Drug Dosing for Renoprotection: Maybe It's Time for a Drug Efficacy-Safety Score?
- (2009) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Supramaximal Dose of Candesartan in Proteinuric Renal Disease
- (2009) E. Burgess et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
- (2009) H.-H. Parving et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aliskiren Fails to Lower Blood Pressure in Patients Who Have Either Low PRA Levels or Whose PRA Falls Insufficiently or Reactively Rises
- (2008) J. E. Sealey et al. AMERICAN JOURNAL OF HYPERTENSION
- Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review
- (2008) Andrew S. Bomback et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
- (2008) Leszek Tylicki et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Aliskiren
- (2008) Morris J. Brown CIRCULATION
- Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
- (2008) John J.V. McMurray et al. Circulation-Heart Failure
- Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial
- (2008) K. J. Schjoedt et al. DIABETOLOGIA
- Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker
- (2008) Yoshiyuki FURUMATSU et al. HYPERTENSION RESEARCH
- Safety and Tolerability of Angiotensin-Converting Enzyme Inhibitor Versus the Combination of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Patients With Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) Rachid Lakhdar et al. JOURNAL OF CARDIAC FAILURE
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren: the first renin inhibitor for clinical treatment
- (2008) Chris Jensen et al. NATURE REVIEWS DRUG DISCOVERY
- Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers
- (2008) T. Berl NEPHROLOGY DIALYSIS TRANSPLANTATION
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?
- (2008) Andrew S Bomback et al. Nature clinical practice. Nephrology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started